News

Video

Real World Data on the Use of Ruxolitinib and Treatment Selection in chronic GvHD

Discussion centered around real-world data following the approval of ruxolitinib as a treatment option for patients with chronic GvHD as well as discussing treatment selection for patients with chronic GvHD, with special consideration for treatment sequencing.

Video Player is loading.
Current Time 0:00
Duration 9:10
Loaded: 0%
Stream Type LIVE
Remaining Time 9:10
 
1x
  • Chapters
  • descriptions off, selected
  • captions off, selected
  • en (Main), selected